Rottgen; Peter

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rottgen; Peter.The latest application filed is for "humanized anti-il 10 antibodies for the treatment of systemic lupus erythematosus (sle)".

Company Profile

0.12.7

Rottgen; Peter - Ladenburg DE
Rottgen; Peter - Pulheim N/A DE
Rottgen, Peter - Braunschweig DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE) Grant 9,605,066 - Osterroth , et al. March 28, 2	2017-03-28
Use of antibodies for detection of IL-10 Grant 9,540,436 - Osterroth , et al. January 10, 2	2017-01-10
Transfer device for transferring bulk material Grant 9,334,130 - Weber , et al. May 10, 2	2016-05-10
Humanized Anti-il 10 Antibodies For The Treatment Of Systemic Lupus Erythematosus (sle) App 20150218270 - OSTERROTH; Frank ; et al.	2015-08-06
Humanized Anti-il 10 Antibodies For The Treatment Of Systemic Lupus Erythematosus (sle) App 20150064179 - OSTERROTH; FRANK ; et al.	2015-03-05
Humanized anti-IL 10 antibodies for the treatment of systemic lupus erythematosus (SLE) Grant 8,956,607 - Osterroth , et al. February 17, 2	2015-02-17
Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE) Grant 8,852,871 - Osterroth , et al. October 7, 2	2014-10-07
Humanized Anti-il 10 Antibodies For The Treatment Of Systemic Lupus Erythematosus (sle) App 20120321618 - Osterroth; Frank ; et al.	2012-12-20
Humanized Anti-il 10 Antibodies For The Treatment Of Systemic Lupus Erythematosus (sle) App 20120321617 - Osterroth; Frank ; et al.	2012-12-20
Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer types Grant 7,901,677 - Little , et al. March 8, 2	2011-03-08
Single-chain antibody acting against 37 kDa/67 kDa Iaminin receptor as tools for the diagnosis and therapy of prion diseases and cancer, production and use thereof Grant 7,507,797 - Knackmuss , et al. March 24, 2	2009-03-24
Single-chain antibody acting against 37 kda/67 kda laminin receptor as tools for the diagnosis and therapy of prion diseases and cancer, production and use thereof App 20070041977 - Knackmuss; Stefan ; et al.	2007-02-22
Generation of diversity in combinatorial libraries App 20050085633 - Collins, John ; et al.	2005-04-21
Generation of diversity in combinatorial libraries Grant 6,640,192 - Collins , et al. October 28, 2	2003-10-28
Generation of diversity in combinatorial libraries App 20020072594 - Collins, John ; et al.	2002-06-13
Generation of diversity in combinatorial libraries Grant 6,310,191 - Collins , et al. October 30, 2	2001-10-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.